Click to Subscribe & Stay Informed via Email!

Subscribe Here!

Subscribe and stay informed about our latest news and events!
  • Please List your Professional Affiliation
  • This field is for validation purposes and should be left unchanged.

News Article

Mon, April 3, 2017 from 12:00pm - 01:30pm  /  CGIS South, S050

Bitter Pills: The Curious Case of Substandard and Counterfeit Medicines in South Asia

Science and Technology Seminar

Muhammad ZamanProfessor of Biomedical Engineering at Boston University; Visiting Faculty, SAI

Chair: Tarun KhannaJorge Paulo Lemann Professor, Harvard Business School; Director, Harvard South Asia Institute

The discussion about universal health care is meaningless without assurance of quality in health services and health commodities. Despite the major efforts by governments in low and middle income countries to increase access, create insurance schemes for all the citizens and emphasize primary care, quality of pharmaceuticals remains a persistent problem. Estimates suggest that anywhere from 15-30% of all drugs in the world, and upwards of 50% in a number of countries, do not meet the basic quality standards. The markets in Pakistan are flooded with not just counterfeit, but substandard and falsified drugs, and despite investments in digital technologies, the problem remains stubborn. Bad drugs have resulted in several major public health crises in the last five years in the country and subsequent legislation that has failed to address the issue in any appreciable way. This talk will focus at the global challenge, the unique perspective from Pakistan in particular and South Asia in general, and discuss the social, economic and technological developments that have the potential to improve access to quality pharmaceuticals.

Light refreshments will be served.

START
Mon, Apr 3, 2017 at 12:00pm

END
Mon, Apr 3, 2017 at 01:30pm

VENUE
CGIS South, S050
Harvard University

ADDRESS
1730 Cambridge Street
Cambridge MA

0403 Zaman
Share Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn